Immune response
View on Wikipediafrom Wikipedia
An immune response is a physiological reaction which occurs within an organism in the context of inflammation for the purpose of defending against exogenous factors. These include a wide variety of different toxins, viruses, intra- and extracellular bacteria, protozoa, helminths, and fungi which could cause serious problems to the health of the host organism if not cleared from the body.[1]
In addition, there are other forms of immune response. For example, harmless exogenous factors (such as pollen and food components) can trigger allergy; latex and metals are also known allergens. A transplanted tissue (for example, blood) or organ can cause graft-versus-host disease. A type of immune reactivity known as Rh disease can be observed in pregnant women. These special forms of immune response are classified as hypersensitivity. Another special form of immune response is antitumor immunity.
In general, there are two branches of the immune response, the innate and the adaptive, which work together to protect against pathogens. Both branches engage humoral and cellular components.
The innate branch—the body's first reaction to an invader—is known to be a non-specific and quick response to any sort of pathogen . Components of the innate immune response include physical barriers like the skin and mucous membranes, immune cells such as neutrophils, macrophages, and monocytes, and soluble factors including cytokines and complement.[2] On the other hand, the adaptive branch is the body's immune response which is catered against specific antigens and thus, it takes longer to activate the components involved. The adaptive branch include cells such as dendritic cells, T cell, and B cells as well as antibodies—also known as immunoglobulins—which directly interact with antigen and are a very important component for a strong response against an invader.[1]
The first contact that an organism has with a particular antigen will result in the production of effector T and B cells which are activated cells that defend against the pathogen. The production of these effector cells as a result of the first-time exposure is called a primary immune response. Memory T and memory B cells are also produced in the case that the same pathogen enters the organism again. If the organism does happen to become re-exposed to the same pathogen, a secondary immune response will kick in and the immune system will be able to respond in both a fast and strong manner because of the memory cells from the first exposure.[3] Vaccines introduce a weakened, killed, or fragmented microorganism in order to evoke a primary immune response. This is so that in the case that an exposure to the real pathogen occurs, the body can rely on the secondary immune response to quickly defend against it.[4]
Innate part
[edit]
The innate immune response is an organism's first response to foreign invaders. This immune response is evolutionarily conserved across many different species, with all multi-cellular organisms having some sort of variation of an innate response.[5] The innate immune system consists of physical barriers such as skin and mucous membranes, various cell types like neutrophils, macrophages, and monocytes, and soluble factors including cytokines and complement.[2] In contrast to the adaptive immune response, the innate response is not specific to any one foreign invader and as a result, works quickly to rid the body of pathogens.[citation needed]
Pathogens are recognized and detected via pattern recognition receptors (PRR). These receptors are structures on the surface of macrophages which are capable of binding foreign invaders and thus initiating cell signaling within the immune cell. Specifically, the PRRs identify pathogen-associated molecular patterns (PAMPs) which are integral structural components of pathogens. Examples of PAMPs include the peptidoglycan cell wall or lipopolysaccharides (LPS), both of which are essential components of bacteria and are therefore evolutionarily conserved across many different bacterial species.[6]
When a foreign pathogen bypasses the physical barriers and enters an organism, the PRRs on macrophages will recognize and bind to specific PAMPs. This binding results in the activation of a signaling pathway which allows for the transcription factor NF-κB to enter the nucleus of the macrophage and initiate the transcription and eventual secretion of various cytokines such as IL-8, IL-1, and TNFα.[5] Release of these cytokines is necessary for the entry of neutrophils from the blood vessels to the infected tissue. Once neutrophils enter the tissue, like macrophages, they are able to phagocytize and kill any pathogens or microbes.[citation needed]
Complement, another component of the innate immune system, consists of three pathways that are activated in distinct ways. The classical pathway is triggered when IgG or IgM is bound to its target antigen on either the pathogen cell membrane or an antigen-bound antibody. The alternative pathway is activated by foreign surfaces such as viruses, fungi, bacteria, parasites, etc., and is capable of autoactivation due to “tickover” of C3. The lectin pathway is triggered when mannose-binding lectin (MBL) or ficolin aka specific pattern recognition receptors bind to pathogen-associated molecular patterns on the surface of invading microorganisms such as yeast, bacteria, parasites, and viruses.[7] Each of the three pathways ensures that complement will still be functional if one pathway ceases to work or a foreign invader is able to evade one of these pathways (defense in depth principle).[5] Though the pathways are activated differently, the overall role of the complement system is to opsonize pathogens and induce a series of inflammatory responses that help to combat infection.[citation needed]
Adaptive part
[edit]
The adaptive immune response is the body's second line of defense. The cells of the adaptive immune system are extremely specific because during early developmental stages the B and T cells develop antigen receptors that are specific to only certain antigens. This is extremely important for B and T cell activation. B and T cells are extremely dangerous cells, and if they are able to attack without undergoing a rigorous process of activation, a faulty B or T cell can begin exterminating the host's own healthy cells.[8] Activation of naïve helper T cells occurs when antigen-presenting cells (APCs) present foreign antigen via MHC class II molecules on their cell surface. These APCs include dendritic cells, B cells, and macrophages which are specially equipped not only with MHC class II but also with co-stimulatory ligands which are recognized by co-stimulatory receptors on helper T cells. Without the co-stimulatory molecules, the adaptive immune response would be inefficient and T cells would become anergic. Several T cell subgroups can be activated by specific APCs, and each T cell is specially equipped to deal with each unique microbial pathogen. The type of T cell activated and the type of response generated depends, in part, on the context in which the APC first encountered the antigen.[9] Once helper T cells are activated, they are able to activate naïve B cells in the lymph node. However, B cell activation is a two-step process. Firstly, B cell receptors, which are just Immunoglobulin M (IgM) and Immunoglobulin D (IgD) antibodies specific to the particular B cell, must bind to the antigen which then results in internal processing so that it is presented on the MHC class II molecules of the B cell. Once this happens a T helper cell which is able to identify the antigen bound to the MHC interacts with its co-stimulatory molecule and activates the B cell. As a result, the B cell becomes a plasma cell which secretes antibodies that act as an opsonin against invaders.[citation needed]
Specificity in the adaptive branch is due to the fact that every B and T cell is different. Thus there is a diverse community of cells ready to recognize and attack a full range of invaders.[8] The trade-off, however, is that the adaptive immune response is much slower than the body's innate response because its cells are extremely specific and activation is required before it is able to actually act. In addition to specificity, the adaptive immune response is also known for immunological memory. After encountering an antigen, the immune system produces memory T and B cells which allow for a speedier, more robust immune response in the case that the organism ever encounters the same antigen again.[8]
Types of immune response
[edit]
Depending on exogenous demands, several types of immune response (IR) are distinguished. In this paradigm, immune system (both innate and adaptive) and non-immune system cellular and molecular components are organized to optimally respond to distinct exposome challenges.
Currently, several types of IR are classified.[10][11]
Type 1 IR is elicited by viruses, intracellular bacteria, parasites. The actors here are group 1 innate lymphoid cells (ILC1), NK cells, Th1 cells, macrophages, opsonizing IgG isotypes.
Type 2 IR is caused by toxins and multicellular parasites. ILC2, epithelial cells, Th2 lymphocytes, eosinophils, basophils, mast cells, IgE are key players here.
Type 3 IR targets extracellular bacteria and fungi by recruiting ILC3, Th17, neutrophils, opsonizing IgG isotypes.
Additional types of IR can be observed in noninfectious pathologies.[12]
All types of IR have sensor (ILCs, NK cells), adaptive (T and B cells), and effector (neutrophils, eosinophils, basophils, mast cells) parts.[11]
References
[edit]- ^ a b Sompayrac, Lauren (2019). How the immune system works (6th ed.). Hoboken, NJ. ISBN 978-1-119-54219-3. OCLC 1083704429.
{{cite book}}: CS1 maint: location missing publisher (link)[page needed] - ^ a b Rich, Robert R.; Fleisher, Thomas A.; Shearer, William T.; Schroeder, Harry W.; Frew, Anthony J.; Weyand, Cornelia M., eds. (2019). Clinical Immunology. doi:10.1016/C2015-0-00344-6. ISBN 978-0-7020-6896-6.[page needed]
- ^ "Immune system – Evolution of the immune system". Encyclopedia Britannica. Retrieved 2020-03-09.
- ^ "vaccine | Definition, Types, History, & Facts". Encyclopedia Britannica. Retrieved 2020-03-09.
- ^ a b c Punt, Jenni (2018). Kuby immunology. Stranford, Sharon A.; Jones, Patricia P.; Owen, Judith A. (8th ed.). New York. ISBN 978-1-4641-8978-4. OCLC 1002672752.
{{cite book}}: CS1 maint: location missing publisher (link)[page needed] - ^ "The Innate Immune System: Early Induced Innate Immunity: PAMPs". faculty.ccbcmd.edu. Archived from the original on 2020-02-01. Retrieved 2020-03-08.[self-published source?]
- ^ Sarma, J. Vidya; Ward, Peter A. (2011). "The complement system". Cell and Tissue Research. 343 (1): 227–235. doi:10.1007/s00441-010-1034-0. ISSN 0302-766X. PMC 3097465. PMID 20838815.
- ^ a b c Bonilla, Francisco A.; Oettgen, Hans C. (February 2010). "Adaptive immunity". Journal of Allergy and Clinical Immunology. 125 (2): S33 – S40. doi:10.1016/j.jaci.2009.09.017. PMID 20061006.
- ^ Janeway, Jr, Charles A.; Travers, Paul; Walport, Mark; Shlomchik, Mark J. (2001). Immunobiology (5th ed.). Garland Science. ISBN 978-0-8153-3642-6.[page needed]
- ^ Annunziato F, Romagnani C, Romagnani S (December 2014). "Adaptive immunity". The Journal of Allergy and Clinical Immunology. 135 (3): 626–635. doi:10.1016/j.jaci.2014.11.001. PMID 25528359.
- ^ a b Murphy K, Weaver C (2016). Janeway's Immunobiology (9th ed.). Garland Science. p. 451. ISBN 978-0-8153-4584-8.
- ^ Eyerich, K.; Eyerich, S. (May 2018). "Immune response patterns in non-communicable inflammatory skin diseases". Journal of the European Academy of Dermatology and Venereology. 32 (5): 692–703. doi:10.1111/jdv.14673. PMC 5947562. PMID 29114938.
Wikimedia Commons has media related to Immune response.
| International | |
|---|---|
| National | |
| Other | |
Immune response
View on Grokipediafrom Grokipedia
Overview
Definition and Importance
The immune response refers to the coordinated physiological reaction of the immune system to foreign substances, termed antigens, or to damaged self-cells, encompassing processes of recognition, activation, and effector-mediated elimination to safeguard the host.[1] This multifaceted defense integrates innate mechanisms, which provide rapid, nonspecific protection, and adaptive mechanisms, which offer antigen-specific targeting and immunological memory.[7] The immune response is essential for preventing microbial infections, including those caused by bacteria, viruses, fungi, and parasites, thereby preserving tissue integrity and overall homeostasis.[8] Dysregulation of this response can lead to immunodeficiencies, chronic inflammation, or autoimmune disorders, underscoring its critical role in health and disease resistance.[7] Evolutionarily, these mechanisms are highly conserved among vertebrates, reflecting their indispensable function in survival against diverse environmental threats.[8] In scope, the immune response builds upon but is distinct from passive non-immune barriers, such as the skin or mucosal linings, by actively mobilizing cellular and soluble factors to detect and neutralize invaders rather than merely providing a physical shield.[1]Key Components and Organs
The immune system's cellular components primarily consist of leukocytes, a diverse group of white blood cells derived from hematopoietic stem cells in the bone marrow.[9] Key leukocyte subtypes include neutrophils, which constitute the majority of circulating white blood cells and serve as rapid responders; macrophages, which are tissue-resident phagocytes; dendritic cells, specialized for antigen capture; and lymphocytes, encompassing T cells and B cells that are central to adaptive immunity.[9] These cells differentiate from common myeloid and lymphoid progenitors, enabling a coordinated network for immune surveillance.[9] Soluble molecules form another critical layer of the immune response, facilitating communication and direct pathogen neutralization. Antibodies, also known as immunoglobulins, are Y-shaped proteins produced by B cells that bind specifically to antigens on pathogens or infected cells.[10] Cytokines are a broad class of small signaling proteins, including interleukins and interferons, secreted by various immune cells to regulate inflammation, cell proliferation, and recruitment.[4] The complement system comprises over 30 plasma proteins that amplify immune reactions through cascades leading to pathogen lysis and opsonization.[11] Anatomical sites are essential for immune cell development, maturation, and encounter with antigens. Primary lymphoid organs include the bone marrow, where B cells mature and all leukocytes originate, and the thymus, a site for T cell education and selection.[12] Secondary lymphoid organs, such as lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), act as hubs for immune cell interactions; lymph nodes filter lymph and facilitate T and B cell responses, while the spleen monitors blood for pathogens, and MALT protects mucosal surfaces like the gut and respiratory tract.[12] Immune cells and molecules are distributed via circulatory systems to ensure systemic coverage. Blood transports leukocytes and soluble factors like antibodies and cytokines throughout the body, while the lymphatic system collects interstitial fluids, antigens, and cells from tissues, directing them to lymph nodes.[5] Interstitial fluids in tissues provide a local milieu for initial immune detection, enabling rapid trafficking of cells like dendritic cells to lymphoid organs.[13]Innate Immune Response
First-Line Defenses
The first-line defenses of the innate immune system consist of non-specific physical, chemical, and mechanical barriers that prevent pathogens from entering the body, acting as the initial shield before any cellular responses are triggered. These barriers are present at all times and function without prior exposure to antigens, providing immediate protection at potential entry sites such as the skin, respiratory tract, gastrointestinal system, and genitourinary tract. By blocking or inhibiting microbial adhesion and proliferation, they significantly reduce the risk of infection from bacteria, viruses, and other invaders. Physical barriers form the outermost layer of defense, primarily through the intact skin and mucous membranes that line internal cavities exposed to the external environment. The skin's stratified squamous epithelium and keratinized outer layer create a tough, impermeable shield that resists penetration by most pathogens, while desquamation— the shedding of dead skin cells—further removes attached microbes. Mucous membranes, found in the respiratory, digestive, and urogenital tracts, are coated with a viscous mucus layer that traps particles and microorganisms, preventing direct contact with underlying tissues. In the respiratory tract, cilia—microscopic hair-like projections on epithelial cells—beat rhythmically to propel mucus and trapped pathogens upward toward the throat for expulsion. Chemical barriers complement physical ones by producing substances that directly damage or inhibit pathogens. Antimicrobial peptides, such as defensins produced by epithelial cells, disrupt microbial cell membranes and exhibit broad-spectrum activity against bacteria, fungi, and enveloped viruses at mucosal surfaces. Lysozyme, an enzyme abundant in tears, saliva, and nasal secretions, hydrolyzes peptidoglycan in bacterial cell walls, effectively lysing Gram-positive bacteria and contributing to the sterility of ocular and oral environments. Low pH environments provide additional antimicrobial action; the stomach's hydrochloric acid maintains a pH of 1.5–3.5, denaturing proteins and killing ingested pathogens, while the vaginal mucosa's acidic pH of 3.8–4.5, maintained by lactic acid from lactobacilli, inhibits the growth of opportunistic microbes like Candida and bacterial vaginosis-associated species. Mechanical barriers enhance clearance through dynamic processes that physically remove pathogens from entry points. Peristalsis, the wave-like muscular contractions in the gastrointestinal and urinary tracts, propels contents along, dislodging and expelling adhered microbes before they can colonize tissues. Mucus flow in the respiratory and gastrointestinal tracts continuously sweeps trapped pathogens away, often aided by coughing or swallowing. Flushing mechanisms, such as the flow of urine through the urinary tract and tears across the eyes, wash away microbes attempting to ascend or adhere to these surfaces, maintaining sterility in otherwise vulnerable areas. These barriers are exemplified in their roles at key portals: in the respiratory tract, the combination of mucus, cilia, and lysozyme blocks inhaled bacteria and viruses like influenza from reaching the lungs, while in the gastrointestinal tract, low pH, peristalsis, and defensins neutralize and expel ingested pathogens such as Salmonella. If breached, these defenses signal the activation of subsequent innate cellular mechanisms.Cellular and Molecular Mechanisms
The innate immune system's cellular and molecular mechanisms rely on pattern recognition receptors (PRRs) to detect invading pathogens through conserved molecular signatures known as pathogen-associated molecular patterns (PAMPs).[14] Among these, Toll-like receptors (TLRs) form a major family of PRRs, with TLR4 recognizing lipopolysaccharide (LPS) from Gram-negative bacteria and TLR5 detecting flagellin from motile bacteria.00122-5) Upon PAMP binding, TLRs trigger intracellular signaling cascades, such as the MyD88-dependent pathway, leading to the production of proinflammatory cytokines and activation of antimicrobial responses.[15] Phagocytes, including macrophages and neutrophils, serve as key cellular effectors in the innate response by engulfing and destroying pathogens via phagocytosis.30065-6) Macrophages patrol tissues and initiate phagocytosis upon PRR engagement, forming a phagosome that fuses with lysosomes to degrade the engulfed material.[16] Neutrophils, rapidly recruited to infection sites, exhibit enhanced phagocytic capacity and release neutrophil extracellular traps (NETs) to ensnare and kill extracellular pathogens.[17] Natural killer (NK) cells contribute cytotoxicity against virus-infected cells and tumor cells by recognizing the absence of major histocompatibility complex class I molecules, releasing perforin and granzymes to induce target cell apoptosis.[18] The complement system acts as a soluble molecular effector, activated through three pathways to amplify innate defenses.[19] The classical pathway initiates via antibody binding to antigens, the alternative pathway spontaneously activates on microbial surfaces, and the lectin pathway recognizes carbohydrate patterns on pathogens, all converging on C3 convertase formation.81503-2) Complement activation promotes opsonization by C3b tagging pathogens for phagocytosis, direct lysis via the membrane attack complex, and inflammation through anaphylatoxins like C5a that recruit immune cells.[19] Pathogen elimination involves diverse killing mechanisms orchestrated by innate cells, particularly neutrophils. Within phagosomes, neutrophils generate reactive oxygen species (ROS) via the NADPH oxidase complex, creating a toxic environment that damages microbial proteins and DNA.[20] Nitric oxide (NO), produced by inducible nitric oxide synthase, further contributes to nitrosative stress and pathogen inhibition. Additionally, neutrophils deploy antimicrobial granules containing enzymes like myeloperoxidase and cationic peptides such as defensins, which disrupt microbial membranes and amplify ROS effects.[21] These mechanisms collectively drive pathogen clearance and link to downstream inflammatory responses.[19]Inflammatory Response
The inflammatory response is a fundamental component of the innate immune system, representing a localized, rapid reaction to tissue injury, infection, or foreign invaders that aims to eliminate the threat and initiate repair processes.[22] This response is orchestrated by resident immune cells and vascular endothelium, bridging immediate physical barriers to more targeted defenses. It is triggered by pattern recognition receptors (PRRs) detecting microbial or damage signals, setting off a cascade of events to contain and resolve the insult.[23] The process unfolds in distinct stages, beginning with vascular changes that enhance delivery of immune effectors to the affected site. Vasodilation, mediated by local release of factors, increases blood flow, causing erythema (redness) and warmth, while elevated vascular permeability allows plasma proteins and fluid to leak into tissues, leading to edema (swelling).[22] These alterations are rapidly induced within minutes to hours following injury. Subsequently, cellular recruitment occurs through chemotaxis, where chemokines—small signaling proteins—guide neutrophils and monocytes from the bloodstream to the site via gradients, enabling phagocytosis and pathogen clearance.[23] Key mediators drive these stages, primarily released by mast cells, macrophages, and endothelial cells. Mast cells degranulate to liberate histamine, which promotes immediate vasodilation and permeability, while prostaglandins, synthesized via cyclooxygenase pathways, amplify these effects and contribute to pain sensitization.[22] Macrophages and other innate cells produce pro-inflammatory cytokines such as interleukin-1 (IL-1) and tumor necrosis factor-alpha (TNF-α), which further recruit leukocytes, induce fever, and activate endothelial adhesion molecules to facilitate cell extravasation.[23] The cardinal signs of inflammation—redness, heat, swelling, and pain—reflect these underlying changes and were first described by the Roman physician Celsus. Pain arises from nerve stimulation by prostaglandins and bradykinin, alerting the host to protect the injured area.[22] Acute inflammation typically resolves within days once the trigger is neutralized, serving a protective role; in contrast, chronic inflammation persists for weeks or longer due to unresolved stimuli or dysregulated signaling, leading to fibrosis and tissue remodeling rather than repair.[23] Resolution of inflammation is an active, programmed process essential for preventing excessive tissue damage and restoring homeostasis. Anti-inflammatory cytokines like IL-10, secreted by regulatory macrophages and T cells, suppress pro-inflammatory mediator production, inhibit leukocyte recruitment, and promote apoptotic clearance of spent neutrophils, thereby limiting collateral injury.[22] This phase ensures that the response does not escalate into pathology, highlighting inflammation's dual nature as both defensive and potentially destructive.[23]Adaptive Immune Response
Antigen Recognition and Processing
Antigens in the adaptive immune response are broadly classified into exogenous and endogenous types. Exogenous antigens originate from extracellular pathogens, such as bacteria, and are typically internalized by antigen-presenting cells (APCs) through endocytosis or phagocytosis.[24] Endogenous antigens, in contrast, arise from intracellular sources like viral proteins synthesized within infected host cells or abnormal self-proteins in cancer cells.[24] These distinctions determine the specific processing pathways that prepare antigenic peptides for presentation on major histocompatibility complex (MHC) molecules, enabling T cell recognition. The MHC class I pathway processes endogenous antigens for presentation to CD8+ cytotoxic T cells. Cytosolic proteins are ubiquitinated and degraded by the proteasome into peptides, which are then transported into the endoplasmic reticulum (ER) via the transporter associated with antigen processing (TAP).[25] In the ER, peptides bind to nascent MHC class I molecules with assistance from chaperones such as calreticulin and tapasin, stabilizing the complex for transport to the cell surface.[25] This pathway surveys intracellular threats, alerting CD8+ T cells to eliminate infected or malignant cells.[26] In parallel, the MHC class II pathway handles exogenous antigens for CD4+ helper T cells. Antigens are taken up into endosomal vesicles, where acidic conditions and proteases like cathepsin S degrade them into peptides.[27] MHC class II molecules, synthesized in the ER and protected by the invariant chain (Ii) to prevent premature peptide binding, traffic to late endosomal compartments called MHC class II compartments (MIICs).[27] There, Ii is proteolytically removed, leaving the CLIP fragment, which is exchanged for antigenic peptides facilitated by HLA-DM; the resulting peptide-MHC class II complexes are displayed on the surface.[27] This process amplifies immune coordination by activating CD4+ T cells.[26] Professional APCs, including dendritic cells, macrophages, and B cells, are central to antigen presentation, as they efficiently process and display peptides on both MHC class I and II molecules.[28] Dendritic cells excel in capturing antigens via innate mechanisms and migrating to lymph nodes for T cell priming, while macrophages handle phagocytosed pathogens and B cells present antigens specific to their B cell receptors.[28] Full T cell activation requires co-stimulatory signals alongside antigen presentation; notably, the interaction between B7 molecules (CD80/CD86) on APCs and CD28 on T cells provides this essential second signal, preventing anergy and promoting proliferation.30149-2) Innate immune responses facilitate antigen delivery to these APCs by initial pathogen capture.[24]Lymphocyte Activation and Differentiation
Lymphocyte activation begins when naive T and B cells encounter their specific antigens, typically presented by antigen-presenting cells in secondary lymphoid organs such as lymph nodes.[29] This process triggers signal transduction through the T cell receptor (TCR) or B cell receptor (BCR), leading to clonal expansion and differentiation into specialized subsets that amplify and direct the adaptive immune response.[30] T cell activation primarily occurs in lymph nodes, where naive CD4+ helper T cells interact with dendritic cells presenting peptide-MHC class II complexes.[29] Upon activation, these cells proliferate via clonal expansion, driven by interleukin-2 (IL-2), which binds to the high-affinity IL-2 receptor to promote cell cycle progression and survival.[31] Differentiation of naive CD4+ T cells into effector subsets—such as Th1 (promoted by IL-12 for intracellular pathogen defense), Th2 (driven by IL-4 for extracellular parasites), Th17 (induced by IL-6 and TGF-β for fungal and bacterial responses), and regulatory T cells (Tregs, fostered by TGF-β for immune suppression)—is orchestrated by the cytokine milieu and transcription factors like T-bet, GATA3, RORγt, and Foxp3, respectively.[32] CD8+ cytotoxic T cells similarly undergo activation and clonal expansion in lymph nodes, differentiating into effectors that target infected cells, with a subset persisting as memory cells for long-term immunity.[33] Ultimately, activated T cells differentiate into short-lived effector cells that execute immediate responses or long-lived central and effector memory cells that patrol tissues and rapidly reactivate upon re-exposure.[34] B cell activation contrasts by occurring through two main pathways: T-dependent and T-independent. In T-dependent activation, B cells in lymphoid follicles recognize antigens via BCR, internalize and present them to CD4+ helper T cells in a process called linked recognition, leading to T cell-dependent proliferation and differentiation.[35] This pathway drives germinal center formation in lymph nodes or spleen, where B cells undergo somatic hypermutation and affinity maturation, selecting high-affinity clones through interactions with follicular dendritic cells and T follicular helper cells.[36] T-independent activation, often triggered by repetitive microbial structures like polysaccharides, bypasses T cell help and results in rapid, low-affinity responses without germinal centers.[37] Like T cells, activated B cells clonally expand, with IL-2 and other signals supporting growth, before differentiating into effector plasma cells or memory B cells that provide durable humoral immunity.[31]Effector Functions
Effector functions represent the terminal phase of the adaptive immune response, where differentiated lymphocytes execute targeted actions to eliminate pathogens and infected cells. Following lymphocyte activation and differentiation, effector T and B cells deploy specialized mechanisms to resolve infections, with cytotoxic CD8+ T cells directly lysing target cells and CD4+ helper T cells amplifying broader immune coordination.[38] Cytotoxic CD8+ T cells, also known as killer T cells, induce apoptosis in infected or malignant cells through the perforin-granzyme pathway. Upon recognizing antigen-MHC class I complexes on target cells, these effectors release perforin, which forms pores in the target cell membrane, allowing granzymes to enter the cytoplasm and activate caspases that trigger programmed cell death. This granule exocytosis mechanism is the primary mode of cytotoxicity for CD8+ T cells, ensuring precise elimination of threats without widespread tissue damage.[39][40] CD4+ helper T cells, in contrast, primarily coordinate immune responses via cytokine secretion rather than direct killing. Differentiated into subsets such as Th1, Th2, Th17, or Tfh cells, they produce signature cytokines like IFN-γ (for macrophage activation and antiviral effects), IL-4 (for B cell class switching and humoral responses), IL-17 (for neutrophil recruitment), and IL-21 (for enhancing CD8+ T cell and B cell functions). These cytokines orchestrate inflammation, antibody production, and cytotoxic responses, amplifying the overall efficacy of adaptive immunity against viruses and other pathogens.[41] B cell effectors, primarily long-lived plasma cells, secrete antibodies of various isotypes that neutralize pathogens and facilitate their clearance. IgM serves as the initial response isotype, effective for agglutination and complement activation due to its pentameric structure; IgG, the most abundant in serum, promotes opsonization, neutralization, and antibody-dependent cellular cytotoxicity (ADCC) through strong Fc receptor binding; IgA protects mucosal surfaces by preventing pathogen adhesion and promoting bacterial aggregation in the gut; IgE mediates anti-parasitic defenses and allergic responses by triggering mast cell degranulation; while IgD's secreted form has a less defined role but may contribute to early immune regulation. These isotype-specific functions are programmed during B cell differentiation, enabling tailored humoral immunity.[42][43] Antibody-dependent cellular cytotoxicity (ADCC) bridges humoral and cellular arms, where natural killer (NK) cells recognize antibody-coated targets via FcγRIIIa (CD16) receptors. Binding triggers NK cell degranulation, releasing perforin and granzymes to lyse the opsonized cell, enhancing clearance of virus-infected or tumor cells without requiring MHC restriction. This mechanism is crucial for therapeutic antibodies, as seen in monoclonal treatments that exploit ADCC for antitumor effects.00188-0)[44] Antibodies further promote pathogen clearance through opsonization, where their Fc regions bind phagocytes like macrophages and neutrophils via Fc receptors, markedly enhancing phagocytosis efficiency. Additionally, IgM and IgG recruit the complement system via the classical pathway, generating C3b for further opsonization and the membrane attack complex for direct lysis, thereby integrating adaptive specificity with innate effector amplification. These processes ensure rapid removal of immune complexes and infected debris, resolving infections and preventing chronic inflammation.[19]00086-4)Integration and Types
Interaction Between Innate and Adaptive
The innate immune system plays a pivotal role in priming the adaptive immune response, primarily through antigen-presenting cells such as dendritic cells (DCs), which link the recognition of pathogen-associated molecular patterns (PAMPs) to effective antigen presentation. Upon encountering PAMPs via pattern recognition receptors like Toll-like receptors (TLRs), DCs internalize and process antigens, presenting them as peptide-major histocompatibility complex (MHC) complexes to naïve T cells in lymphoid organs, thereby initiating adaptive immunity.[45] Additionally, damage-associated molecular patterns (DAMPs) released from damaged cells enhance DC maturation and upregulate co-stimulatory molecules such as CD80 and CD86, providing essential signals for T cell activation and preventing tolerance.[46] This priming ensures that adaptive responses are tailored to the specific threat detected by the innate system. Cytokines serve as critical bridges between the two arms of immunity, with innate cells producing factors that activate and direct adaptive effectors. Type I interferons, secreted by innate immune cells like plasmacytoid DCs in response to viral PAMPs, not only activate natural killer (NK) cells for early cytotoxicity but also prime CD8+ T cells for enhanced proliferation and effector function during subsequent adaptive phases.[47] Similarly, interleukin-12 (IL-12) produced by conventional DCs promotes the differentiation of T helper 1 (Th1) cells, fostering cell-mediated immunity against intracellular pathogens, while coordinating with NK cells to amplify interferon-gamma production.[48] These cytokine signals create a milieu that shapes adaptive lymphocyte responses for optimal pathogen clearance. Feedback loops further integrate the systems, allowing adaptive outputs to enhance innate functions. Antibodies generated by B cells during the adaptive phase bind pathogens via their Fab regions and engage Fc receptors on innate effectors like macrophages and neutrophils, promoting opsonization and phagocytosis to accelerate clearance.[49] This antibody-dependent enhancement also triggers antibody-dependent cellular cytotoxicity (ADCC) by NK cells, linking humoral adaptive responses back to innate killing mechanisms.[45] Evolutionarily, the innate system functions as a rapid first responder, providing immediate defense while instructing the slower, specific, and memory-capable adaptive arm, a paradigm first articulated by Charles Janeway Jr. in 1989. This integration has been conserved across vertebrates, balancing speed and precision to optimize host survival against diverse threats, as evidenced by the coordinated roles of DCs and cytokines in both ancient and modern immune contexts.[50]Humoral vs. Cell-Mediated Responses
The adaptive immune system employs two primary branches—humoral and cell-mediated responses—to combat distinct types of pathogens, with the humoral response focusing on extracellular threats and the cell-mediated response targeting intracellular ones.[51][52] The humoral immune response is antibody-mediated and primarily defends against extracellular pathogens, such as bacteria and toxins, by neutralizing them in bodily fluids to prevent infection or spread.[51] It involves B cells that differentiate into plasma cells upon antigen recognition, secreting immunoglobulins (antibodies) of various classes, including IgM (the initial response for complement activation), IgG (for long-term neutralization and opsonization), IgA (mucosal protection), IgE (parasite and allergy responses), and IgD (B cell regulation).[53] These antibodies bind to antigens, marking them for destruction by phagocytes or complement-mediated lysis, effectively halting pathogen dissemination without directly invading host cells.[54] In contrast, the cell-mediated immune response is orchestrated by T lymphocytes and targets intracellular threats, including viruses, intracellular bacteria, and cancer cells, by directly eliminating infected or abnormal host cells.[52] Cytotoxic CD8+ T cells recognize antigens presented on MHC class I molecules and induce apoptosis in infected cells through perforin and granzyme release, preventing pathogen replication.[55] Helper CD4+ T cells, particularly Th1 subsets, activate macrophages to enhance their killing capacity against engulfed intracellular pathogens, such as by promoting phagolysosome formation.[56] The balance between humoral and cell-mediated responses is regulated by cytokine profiles from CD4+ T helper cells, which direct differentiation into Th1 or Th2 subsets. Th1 cells produce interferon-gamma (IFN-γ) to promote cell-mediated immunity by enhancing macrophage activation and cytotoxic T cell function, while Th2 cells secrete interleukin-4 (IL-4) to drive humoral responses by supporting B cell proliferation, differentiation, and antibody class switching.[57]| Aspect | Humoral Response | Cell-Mediated Response |
|---|---|---|
| Primary Mediators | Antibodies (immunoglobulins) | T lymphocytes (CD4+ and CD8+) |
| Key Cells Involved | B cells and plasma cells | CD8+ cytotoxic T cells, CD4+ helper T cells, macrophages |
| Main Targets | Extracellular pathogens (e.g., bacteria, toxins) | Intracellular pathogens (e.g., viruses, intracellular bacteria), cancer cells |
| Cytokine Drivers | IL-4 (Th2 profile) | IFN-γ (Th1 profile) |
| Effector Mechanism | Neutralization, opsonization, complement activation | Direct cytotoxicity, macrophage activation |